HOME >> BIOLOGY >> NEWS
Possible Trigger For Heart Failure Identified In Lab Animal Studies

DALLAS, April 14 -- Researchers have demonstrated in laboratory animals that tumor necrosis factor alpha, a protein produced in the heart, can lead to congestive heart failure. The finding may pave the way for a new treatment for the nation's fastest-growing heart disease. The studies, from two different research teams, appear in today's Circulation: Journal of the American Heart Association.

Released by the body to help heal injured tissue, tumor necrosis factor alpha (TNF), can initiate an "inflammatory cascade," or immune reaction, that may turn against the heart and weaken it, resulting in congestive heart failure, according to scientists at the University of Texas Southwestern Medical Center in Dallas and Baylor College of Medicine in Houston. One study also found that TNF is produced not just by white blood cells, but also by heart muscle cells called myocytes.

The Dallas scientists demonstrated that laboratory mice who were genetically altered so their heart cells produced an excess of TNF pumped less blood and developed an enlarged heart -- the primary features of congestive heart failure in humans.

Afflicting almost 5 million Americans, congestive heart failure is the single most frequent cause of hospitalizations for people age 65 or older, according to the American Heart Association. From 1979 to 1995, deaths from heart failure increased 115.7 percent.

In the study, researchers developed two lines of transgenic mice which expressed TNF in the heart. The two lines, which included 30 mice, died prematurely of heart failure. The progression of heart failure was directly related to the amount of TNF. Mice which did not express TNF in the heart proved to be free of disease, notes Deborah Bryant, B.S., the study's lead author. She is a senior research associate at U.T. Southwestern's department of pediatrics.

"Production of TNF by cardiac myocytes is sufficient to cause myocardit
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
13-Apr-1998


Page: 1 2 3

Related biology news :

1. Possible new cure for psoriasis
2. Possible link discovered between gene responsible for blood vessel development and ACD in newborns
3. Possible mechanism for link between diabetes and Alzheimers disease discovered
4. Scientists switch components in cell circuits: Possible new technology, therapy
5. Possible new cell type found in developing inner ear
6. Possible gene for form of mental retardation, brain development identified
7. Possible cause and treatment for shock uncovered by UC San Diego bioengineers
8. Reproductive Signals Affect Lifespan In Roundworm C. Elegans, Offering Possible Insight Into Human Aging Process
9. UV Rays, Fire And Flame Retardants To Be Reviewed For Possible Listing As Carcinogens, NTP Announces
10. Coffee Without Addiction, Possible New Treatment For Osteoporosis, Wrinkle-Free Cotton, And More
11. Mechanism For Fungal Adherence Found, Possible Key To Disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Possible Trigger For Heart Failure Identified Lab Animal Studies

(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... it was fascinating to put a flashlight up to ... hand. Washington University in St. Louis engineers are using ... tissues to improve imaging of cancerous tissues and to ... Gene K. Beare Distinguished Professor of Biomedical Engineering at ... a novel time-reversal technology that allows researchers to better ...
(Date:10/31/2014)... In the early 1900s, Brazil was the world,s largest ... were cultivated in a 800, 000 ha region of ... canopy of native shade trees. Whereas the surrounding rainforest ... derived mainly from a handful of seeds introduced in ... variation. According to Brazilian scientist Gonçalo Pereira, "This scenario ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
(Date:11/15/2014)... Biofuels will present at CleanEquity Monaco 2015 on March 5th ... . Logo - http://photos.prnewswire.com/prnh/20141114/158674LOGO ... by Innovator Capital, the London based ... Prince Albert II of Monaco,s ... Monte-Carlo SBM, Oceanographic Museum of Monaco , ...
(Date:11/15/2014)... Nov. 14, 2014  F. David Rollo , ... Who as a Pinnacle Professional in the field of ... of Cell Point, LLC. Cell Point is ... Centennial, Colorado , Houston ... company,s five technology platforms, ethylenedicysteine drug conjugate technology ("EC ...
(Date:11/12/2014)... Research Labs (a registered trade name of ReachBio LLC, ... it has signed an agreement with Funakoshi Co., Ltd. ... distribution rights to ReachBio,s human primary cell product line ... Japan . Under a companion agreement, Funakoshi will ... drug development companies. Photo - http://photos.prnewswire.com/prnh/20141111/157946LOGO ...
(Date:11/12/2014)... (PRWEB) November 11, 2014 ... and one year of achieving GMP compliance with ... clearly defined and impressive blueprint for creating high ... and Requisition process and ending with the final ... where each product is in the process,” explains ...
Breaking Biology Technology:Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3Innovative Formulations Achieves GMP Compliance and Success with InstantGMP™ MES 2
Cached News: